Goldman Sachs’s Foghorn Therapeutics FHTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Sell |
34,901
-21,431
| -38% | -$101K | ﹤0.01% | 4779 |
|
|
2025
Q1 | $206K | Sell |
56,332
-18,324
| -25% | -$66.9K | ﹤0.01% | 4670 |
|
|
2024
Q4 | $352K | Buy |
74,656
+29,099
| +64% | +$137K | ﹤0.01% | 4460 |
|
|
2024
Q3 | $424K | Buy |
45,557
+30,363
| +200% | +$283K | ﹤0.01% | 4190 |
|
|
2024
Q2 | $87.4K | Buy |
15,194
+3,773
| +33% | +$21.7K | ﹤0.01% | 4511 |
|
|
2024
Q1 | $76.6K | Sell |
11,421
-2,820
| -20% | -$18.9K | ﹤0.01% | 4496 |
|
|
2023
Q4 | $91.9K | Sell |
14,241
-1,710
| -11% | -$11K | ﹤0.01% | 4473 |
|
|
2023
Q3 | $79.8K | Buy |
15,951
+734
| +5% | +$3.67K | ﹤0.01% | 4429 |
|
|
2023
Q2 | $107K | Sell |
15,217
-15,858
| -51% | -$112K | ﹤0.01% | 4555 |
|
|
2023
Q1 | $193K | Sell |
31,075
-2,808
| -8% | -$17.4K | ﹤0.01% | 4535 |
|
|
2022
Q4 | $216K | Buy |
33,883
+16,961
| +100% | +$108K | ﹤0.01% | 4472 |
|
|
2022
Q3 | $145K | Buy |
16,922
+544
| +3% | +$4.66K | ﹤0.01% | 4823 |
|
|
2022
Q2 | $223K | Buy |
16,378
+3,233
| +25% | +$44K | ﹤0.01% | 4854 |
|
|
2022
Q1 | $200K | Sell |
13,145
-23,298
| -64% | -$354K | ﹤0.01% | 5096 |
|
|
2021
Q4 | $833K | Buy |
36,443
+23,634
| +185% | +$540K | ﹤0.01% | 4177 |
|
|
2021
Q3 | $178K | Buy |
+12,809
| New | +$178K | ﹤0.01% | 4906 |
|
|
2021
Q1 | – | Sell |
-10,845
| Closed | -$220K | – | 5274 |
|
|
2020
Q4 | $220K | Buy |
+10,845
| New | +$220K | ﹤0.01% | 4228 |
|